Stoke Therapeutics Stock Analysis

Stoke Stock Analysis Notes

About 95.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.94. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Stoke Therapeutics has Price/Earnings To Growth (PEG) ratio of 0.27. The entity recorded a loss per share of 2.08. The firm had not issued any dividends in recent years. Stoke Therapeutics had 1:9 split on the 6th of June 2019. Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide medicines to treat the underlying causes of severe genetic diseases in the United States. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts. Stoke Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people. To find out more about Stoke Therapeutics contact the company at 781 430 8200 or learn more at https://www.stoketherapeutics.com.

Stoke Therapeutics Investment Alerts

Stoke Therapeutics Upcoming and Recent Events

Stoke Largest EPS Surprises

View All Earnings Estimates

Stoke Therapeutics Environmental, Social, and Governance (ESG) Scores

Stoke Stock Institutional Investors

Note, although Stoke Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Stoke Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 436.98 M.

Stoke Profitablity

Management Efficiency

Stoke Therapeutics has return on total asset (ROA) of (0.275) % which means that it has lost $0.275 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5206) %, meaning that it created substantial loss on money invested by shareholders. Stoke Therapeutics' management efficiency ratios could be used to measure how well Stoke Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.43. Return On Capital Employed is expected to rise to -0.63 this year. At this time, Stoke Therapeutics' Total Current Liabilities is quite stable compared to the past year. Non Current Liabilities Total is expected to rise to about 45.8 M this year, although the value of Liabilities And Stockholders Equity will most likely fall to about 213.7 M.

Technical Drivers

As of the 26th of February, Stoke Therapeutics has the Risk Adjusted Performance of (0.06), variance of 22.24, and Coefficient Of Variation of (1,141). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Stoke Therapeutics, as well as the relationship between them.

Stoke Therapeutics Price Movement Analysis

Stoke Therapeutics Insider Trading Activities

Stoke Therapeutics Outstanding Bonds

Stoke Therapeutics Predictive Daily Indicators

Stoke Therapeutics Corporate Filings

Stoke Therapeutics Forecast Models

Stoke Therapeutics' time-series forecasting models are one of many Stoke Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Stoke Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Stoke Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Stoke shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Stoke Therapeutics. By using and applying Stoke Stock analysis, traders can create a robust methodology for identifying Stoke entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Stoke analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Stoke analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Stoke Therapeutics stock analysis indicators help investors evaluate how Stoke Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Stoke Therapeutics shares will generate the highest return on investment. By understating and applying Stoke Therapeutics stock analysis, traders can identify Stoke Therapeutics position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stoke Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Stoke Stock please use our How to buy in Stoke Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stoke Therapeutics. If investors know Stoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stoke Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Stoke Therapeutics is measured differently than its book value, which is the value of Stoke that is recorded on the company's balance sheet. Investors also form their own opinion of Stoke Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Stoke Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stoke Therapeutics' market value can be influenced by many factors that don't directly affect Stoke Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Stoke Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Stoke Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stoke Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.